KU55933 (a specific ATM phosphorylation inhibitor) decreased NF-κB phosphorylation in DNR-treated B-ALL cells (Nalm-6 and Reh cells) (Fig. 5b). The gene discussed is NFKB1; the disease is acute lymphoblastic leukemia.